SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 02/13/2025 at 20:13, 1 year 1 month ago

Sanofi Files 2024 Financial Reports with SEC and AMF

Financial Report 2024 SEC Filing Sanofi AMF Compliance
PRESS RELEASE

published on 02/13/2025 at 20:08, 1 year 1 month ago

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Sanofi files 2024 U.S. Form 20-F and French Annual Financial Report. Documents available online. Company focused on healthcare innovation

Innovation Financial Report Healthcare Form 20-F Sanofi
PRESS RELEASE

published on 02/10/2025 at 19:00, 1 year 1 month ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 02/07/2025 at 07:05, 1 year 1 month ago

Sanofi enters into a €2 billion share buyback mandate

Share Buyback Investment 2025 Sanofi L'Oréal
PRESS RELEASE

published on 02/07/2025 at 07:00, 1 year 1 month ago

Press Release: Execution of a share buyback agreement for up to €2 billion
Sanofi enters €2 billion share buyback agreement for 2025 with investment service provider to repurchase own shares, continuing focus on improvement and innovation in global healthcare sector

Share Buyback Sanofi Global Healthcare Investment Service Provider €2 Billion
BRIEF

published on 02/03/2025 at 07:35, 1 year 1 month ago

Sanofi Acquires Shares from L’Oréal in Strategic Buyback

Shareholder Value Share Buyback Finance Sanofi L’Oréal
PRESS RELEASE

published on 02/03/2025 at 07:30, 1 year 1 month ago

Press Release: Sanofi announces buy back of shares from L’Oréal
Sanofi acquires 2.3% of shares from L’Oréal as part of buyback program, aligning with capital allocation policy & creating shareholder value. Transaction structured as off-market block trade

Acquisition Share Buyback Program Sanofi L’Oréal Sustainable Value Creation
PRESS RELEASE

published on 01/30/2025 at 07:30, 1 year 1 month ago

Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
BRIEF

published on 01/22/2025 at 07:05, 1 year 2 months ago

Sarclisa approved in EU for treatment of multiple myeloma

Sanofi Multiple Myeloma Sarclisa European Approval VRd Treatment
PRESS RELEASE

published on 01/22/2025 at 07:00, 1 year 2 months ago

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
EU approves Sarclisa as first anti-CD38 therapy in combination with VRd for transplant-ineligible NDMM based on positive IMROZ study results. Third indication for Sarclisa in the EU

Multiple Myeloma Sarclisa EU Approval VRd Anti-CD38 Therapy

Published on 03/26/2026 at 21:00, 42 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 42 minutes ago

Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 5 hours 22 minutes ago

ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 14:05, 7 hours 37 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 8 hours 42 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 53 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 2 hours 21 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 2 hours 28 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 2 hours 32 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:57, 2 hours 44 minutes ago

DSH-Director/PDMR Shareholding

View all EQS

Published on 03/26/2026 at 18:17, 3 hours 25 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 3 hours 57 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 12 hours 44 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 14 hours 12 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 1 day 2 hours ago

LNA SANTE : 2025 Annual Results

View all LES ECHOS COMFI WIRE

News